- HCPEA named Geoff Lieberthal (H.I.G. Capital) as Board Chair and Fazle Husain (CVC Capital Partners) as Vice Chair.
- The new leadership signals a focus on private-equity-backed healthcare innovation aimed at improving access, quality, and equity.
- Founded in 2010, HCPEA represents 1,200+ professionals across 100+ firms as the leading PE trade group dedicated to healthcare.
- Lieberthal and Husain bring decades of investing experience across provider services, payor services, devices, pharma, and health tech.
Read More
The recent leadership change in HCPEA—appointing Geoff Lieberthal as Board Chair and Fazle Husain as Vice Chair—reflects a strategic reorientation towards broader impact metrics in healthcare investing. Both leaders have deep experience across sub-sectors, implying an agenda that goes beyond financial returns to integrate reinvestment in access, quality, and equity.
This is timely given growing pressure on the private equity sector in healthcare to demonstrate alignment with public health goals. The emphasis on “responsible investing” and “innovation” suggests HCPEA may pursue policy advocacy, ESG frameworks, and partnerships with public agencies.
With HCPEA representing 1,200+ professionals from 100+ firms, the association commands significant influence over buy-side practices, standards, and norms. Hence, leadership changes at the board level are likely to ripple through deal structuring, diligence, and operational standards across healthcare PE.
Lieberthal’s background—spanning provider services, payor services, and healthcare tech—joint with Husain’s global sector-spanning investing history, suggest that HCPEA under their leadership may push for more interdisciplinary investments and expand cross-border or cross-segment activity. Additionally, as fund managers increasingly incorporate health equity and access metrics into their investment thesis, HCPEA has opportunity to standardize metrics or guidelines.
Open questions include: How HCPEA plans to measure and report on healthcare equity outcomes; what policy priorities the organization will adopt under this leadership; how firms represented will balance risk-return trade-offs in sectors with high social impact; whether new member firms with differing strategies will align with the new direction.
Supporting Notes
- HCPEA appointed Geoff Lieberthal (Managing Director, H.I.G. Capital) as Board Chair.
- HCPEA appointed Fazle Husain (Head of US Healthcare, CVC Capital Partners) as Vice Chair.
- Lieberthal has nearly 20 years investing in U.S. healthcare across provider services, payor services, and health technology.
- Husain has over 25 years of global experience investing in healthcare service, medical devices, specialty pharmaceuticals, and healthcare information technology.
- HCPEA is a nonprofit trade association founded in 2010, dedicated to convening the healthcare investment community; its membership comprises over 1,200 professionals representing more than 100 firms.
- HCPEA’s strategic goals under the new leadership will include building a better future in healthcare and supporting innovation that addresses challenges like access, quality, and equity.